Terumo Corporation (TSE: 4543) announced today on Human Rights Day, that it has established the "Terumo Group Human Rights Policy".
Since its founding in 1921, Terumo has led business guided by the group mission of "Contributing to Society through Healthcare", and has respected the rights of various stakeholders including patients, healthcare providers, and associates.
As a global leader in the healthcare industry, the company has signed the United Nations Global Compact in 2012, agreeing to the corporate sustainability initiative including the respect for human rights. Furthermore, in 2019 Terumo has established the group "Core Values" to be shared by and connect associates worldwide. The Core Values define acts of respect and integrity, as well as the care for patients, as an important principle all Terumo associates should reflect. The "Terumo Group Code of Conduct" also states the "Respect for Human Rights" as every associate's guide to day-to-day business activities.
Additionally, the "Terumo Group Procurement Policy" and "Supplier Guidelines" address the respect of human rights, as well as requesting external business partners such as material and service suppliers to consider human rights.
The "Terumo Group Human Rights Policy" aims to clarify Terumo Group's position and responsibility on human rights, which are described in the existing policies, and express its commitment to promote human rights. The policy supports and respects the United Nation's "Guiding Principles on Business and Human Rights". As a company that provides products and services relating to the lives and health of people, the policy identifies the importance of human rights, prioritizing specific themes such as creating safe and worker-friendly environments, complying with fair labor practices, and ensuring the quality and safety of products and services.
The policy will be applied to the entire Terumo group. Terumo aims to advance respect for human rights, in order to strive to become a socially trusted company, and to contribute to achieving a sustainable society.
Terumo Group Regulations and Standards:
Human Rights Day is observed every year on December 10, to commemorate the Universal Declaration of Human Rights. The declaration was adopted by the United Nations General Assembly in December 10, 1948 as a common standard of achievement for all peoples and all nations. It articulates fundamental human rights such as social, cultural, economic and political rights to be universally protected.
Tokyo-based Terumo Corporation is one of the world's leading medical device manufacturers, with approximately US$6 billion in sales and operations in more than 160 nations. Founded in 1921, the company develops, manufactures and distributes world-class medical devices, including products for use in cardiothoracic surgery, interventional procedures and transfusion medicine; the company also manufactures a broad array of syringe and hypodermic needle products for hospital and physician-office use. Terumo contributes to society by providing valued products and services to the healthcare market, and by responding to the needs of healthcare providers and the people they serve. Terumo Corporation's shares are listed on the first section of the Tokyo Stock Exchange (No. 4543, Reuters symbol <4543.T>, or Bloomberg 4543: JP) and is a component of the Nikkei 225, Japan's leading stock index.
Corporate Communication Dept., Terumo Corporation
(Notice) Among the information that Terumo discloses, the forward-looking statements including financial projections are based upon our assumptions using information available to us at the time and are not intended to be guarantees of future events or performance. Accordingly, it should be noted that actual results may differ from those forecasts on projections due to various factors. Factors affecting to actual results include, but are not limited to, changes in economic conditions surrounding Terumo, fluctuations of foreign exchange rates, and state of competition. The market share information in this press release is partly derived from our own independent research.
This is HCP only content